The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
Abstract
Tissue plasminogen activator (tPA) has been shown to improve 3-month outcome in stroke patients treated within 3 hours of symptom onset. The costs associated with this new treatment will be a factor in determining the extent of its utilization. Data from the NINDS rt-PA Stroke Trial and the medical literature were used to estimate the health and economic outcomes associated with using tPA in acute stroke patients. A Markov model was developed to estimate the costs per 1,000 patients eligible for treatment with tPA compared with the costs per 1,000 untreated patients. One-way and multiway sensitivity analyses (using Monte Carlo simulation) were performed to estimate the overall uncertainty of the model results. In the NINDS rt-PA Stroke Trial, the average length of stay was significantly shorter in tPA-treated patients than in placebo-treated patients (10.9 versus 12.4 days; p = 0.02) and more tPA patients were discharged to home than to inpatient rehabilitation or a nursing home (48% versus 36%; p = 0.002). The Markov model estimated an increase in hospitalization costs of $1.7 million and a decrease in rehabilitation costs of $1.4 million and nursing home cost of $4.8 million per 1,000 eligible treated patients for a health care system that includes acute through long-term care facilities. Multiway sensitivity analysis revealed a greater than 90% probability of cost savings. The estimated impact on long-term health outcomes was 564 (3 to 850) quality-adjusted life-years saved over 30 years of the model per 1,000 patients. Treating acute ischemic stroke patients with tPA within 3 hours of symptom onset improves functional outcome at 3 months and is likely to result in a net cost savings to the health care system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Self-citationSimulation and the Monte Carlo Method
Rubinstein, R. Y. (1981) · Wiley series in probability and statistics · doi:10.1002/9780470316511 · Cited by 2,450
Early Hemorrhage Growth in Patients With Intracerebral Hemorrhage
Brott, T., Broderick, J., Kothari, R., Barsan, W., Tomsick, T., Sauerbeck, L., Spilker, J., Duldner, J., & Khoury, J. (1997) · Stroke · doi:10.1161/01.str.28.1.1 · Cited by 1,477
Self-citationSuarez, F. L., Savaiano, D. A., & Levitt, M. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330101 · Cited by 507
Chiu, D., Krieger, D., Villar-Cordova, C., Kasner, S. E., Morgenstern, L. B., Bratina, P. L., Yatsu, F. M., & Grotta, J. C. (1998) · Stroke · doi:10.1161/01.str.29.1.18 · Cited by 406
Self-citationFactors That Predict the Bleeding Risk of Cerebral Arteriovenous Malformations
Pollock, B. E., Flickinger, J. C., Lunsford, L. D., Bissonette, D. J., & Kondziolka, D. (1996) · Stroke · doi:10.1161/01.str.27.1.1 · Cited by 370
(1995) · New England Journal of Medicine · doi:10.1056/nejm199501053320101 · Cited by 263
Epidemiological characteristics of lacunar infarcts in a population.
Sacco, S. E., Whisnant, J. P., Broderick, J. P., Phillips, S. J., & O'Fallon, W. M. (1991) · Stroke · doi:10.1161/01.str.22.10.1236 · Cited by 181
Self-citationTilley, B. C., Lyden, P. D., Brott, T. G., Lü, M., Levine, S. R., & Welch, K. M. A. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550240020008 · Cited by 136
Self-citationTranscranial Doppler assessment of cerebral flow velocity during cognitive tasks.
Kelley, R. E., Chang, J., Scheinman, N. J., Levin, B. E., DUNCAN, R. C., & Lee, S. C. (1992) · Stroke · doi:10.1161/01.str.23.1.9 · Cited by 127
Cited by
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
Recommendations for the Establishment of Primary Stroke Centers
Alberts, M. J. (2000) · JAMA · doi:10.1001/jama.283.23.3102 · Cited by 725
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: The Cleveland Area Experience
Katzan, I. L., Furlan, A. J., Lloyd, L. E., Frank, J. I., Harper, D. L., Hinchey, J. A., Hammel, J. P., Qu, A., & Sila, C. A. (2000) · JAMA · doi:10.1001/jama.283.9.1151 · Cited by 648
Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Kwiatkowski, T. G., Libman, R. B., Frankel, M., Tilley, B. C., Morgenstern, L. B., Lu, M., Broderick, J. P., Lewandowski, C. A., Marler, J. R., Levine, S. R., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402302 · Cited by 647
Self-citation
Metadata
- Authors
- Fagan, S. C., Morgenstern, L. B., Petitta, A., Ward, R. E., Tilley, B. C., Marler, J. R., Levine, S. R., Broderick, J. P., Kwiatkowski, T. G., Frankel, M., Brott, T. G., Walker, M. D., & The NINDS rt-PA Stroke Study Group*
- Venue
- Neurology
- Published
- 1998-04
- Volume
- 50
- Issue
- 4
- Pages
- 883-890
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1983567452
- Cited by
- 385
- References
- 14
- FWCI
- 17.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. https://app.cochat.ai/papers/10.1212/wnl.50.4.883
- The paper
- Fagan, S. C., Morgenstern, L. B., Petitta, A., Ward, R. E., Tilley, B. C., Marler, J. R., Levine, S. R., Broderick, J. P., Kwiatkowski, T. G., Frankel, M., Brott, T. G., Walker, M. D., & The NINDS rt-PA Stroke Study Group*. (1998). Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology. https://doi.org/10.1212/wnl.50.4.883
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.